Kleiner Perkins Caufield & Byers are passionately committed to helping their portfolio companies succeed. KPCB has built a powerful network of scientists, executives, policy experts and business development activities so that we can help young companies translate their dreams from "bench to bedside" faster and more effectively.
MPM focuses equally on capturing and creating value. MPM captures value by identifying under-appreciated assets and by understanding risk. MPM "creates" value by doing whatever it takes to help their companies succeed.
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested in more than 135 companies.
Baxalta Ventures invests globally in healthcare companies developing novel products and therapies consistent with Baxalta’s commitment to strive for excellence on behalf of patients, caregivers and healthcare providers. The Baxalta Ventures team brings unique expertise in products and therapies across the pharmaceuticals, medical devices, and biotechnology sectors. As part of Baxalta, we have access to additional expertise in product research, development, manufacturing, and commercialization to our work with entrepreneurs.
OrbiMed is dedicated exclusively to the healthcare sector, with over $14 billion in assets under management. OrbiMed seeks to be a capital provider of choice, with the flexibility to provide equity and debt capital solutions that are tailored to the unique needs of their portfolio companies. The firm’s global team of over 80 professionals brings the resources and experience required to be an exceptional long-term partner in building world-class healthcare companies.
New Leaf Venture Partners is a leader in healthcare technology venture investing. Our investment professionals bring a unique blend of technical, clinical, and operational experience to our investments, working closely with our entrepreneurs and management teams to help build successful companies. We invest in both public and private biopharmaceutical companies as well as healthcare-related information technology companies. New Leaf currently manages over $1 billion in assets. This includes NLV’s funds, New Leaf Ventures I, L.P., New Leaf Ventures II, L.P., New Leaf Ventures III, L.P. and New Leaf Growth Fund I, L.P. New Leaf was formed in 2005 as the healthcare spinoff from the Sprout Group, one of the oldest U.S. venture capital funds.
Cowen Private Investments is a private investment fund sponsored by an affiliate of Cowen Group, Inc., a diversified financial services firm. Cowen Private Investments focuses its investments in private life sciences companies and is committed to investing in emerging life sciences companies where it can partner with management teams to help build marquee companies dedicated to solving serious medical issues.
Founded in 1999, Perceptive Advisors is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare. Our dedicated team of industry experts uses a unique balance of scientific, technical and investment expertise to identify opportunities. We seek to evaluate opportunities without biases by analyzing and weighing critical data and catalysts assessing the balance between market perception and reality. Perceptive manages approximately $1 billion across our strategies and has a long and successful track record.
HBM Healthcare Investments invests in the healthcare sector. The Company holds and manages an international portfolio of promising companies in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided in their strategic direction. This is what makes HBM Healthcare Investments an interesting alternative to investments in big pharma and biotechnology companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).
Redmile Group invests globally in healthcare companies across asset classes. Through a dedicated senior investment team and a deep network of healthcare relationships, Redmile looks to partner with and provide guidance to exceptional healthcare companies throughout their lifecycle.
Franklin Templeton Investments, with more than 65 years of investment experience, provides global and domestic investment management to retail, institutional and sovereign wealth clients in over 180 countries. Through specialized teams, the company has expertise across all asset classes — including equity, fixed income, alternative and custom solutions. The company’s more than 600 investment professionals are supported by its integrated, worldwide team of risk management professionals and global trading desk network. For more information visit franklintempleton.com.